-
-
-
-
-
-
-
Sonoma Pharmaceuticals prices $4 million public offering at $1.35 per share
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
-
-
-
-
-
-
-
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
-
459,030 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

